Haft, Michael A.
Park, Helen H.
Lee, Stephanie S.
Sprague, Jessica M.
Paller, Amy S.
Cotton, Colleen H.
Thyssen, Jacob P.
Eichenfield, Lawrence F. http://orcid.org/0000-0002-2760-0474
Article History
Accepted: 28 April 2023
First Online: 24 May 2023
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: Dr Haft has no conflicts of interest to report. Dr Park has no conflicts of interest to report. Dr Lee has no conflicts of interest to report. Dr Sprague has no conflicts of interest to report. Dr Paller reports the following: AbbVie, Eli Lilly, Incyte, Regeneron—investigator; Abbvie, Almirall, Arcutis, Arena, BiomX, Bristol Myers Squibb, Catawba, Eli Lilly, Galderma, Gilead, Incyte, Janssen, Leo, Novartis, Pfizer, RAPT, Regeneron, Sanofi/Genzyme, Seanergy—consultant with honorarium; Bausch, Galderma—Data Safety Monitoring Board. Dr Cotton did not receive any direct support for this study. She received partial salary support from Regeneron and Sanofi as a sub-investigator of clinical research trials. Dr Thyssen is an advisor for AbbVie, Almirall, Arena Pharmaceuticals, Coloplast, OM Pharma, Aslan Pharmaceuticals, Union Therapeutics, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, a speaker for AbbVie, Almirall, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, and received research grants from Pfizer, Regeneron, and Sanofi-Genzyme. Dr Eichenfield has served as an advisory board member, and/or speaker, consultant, or clinical trial investigator for AbbVie, Arena, Aslan, Bausch, Castle Biosciences, Dermavant, Eli Lilly, Forte, Galderma, Incyte, Leo Pharma, Novartis, Otsuka, Pfizer, Regeneron, Sanofi Genzyme and UCB.
: Reviewed and approved by University of California, San Diego Investigational Review Board; approval #210154. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Informed consent was obtained to publish anonymous survey data. For the photo associated with vignette 1 in the supplementary materials: Image used with permission from VisualDx. For the photo associated with vignette 2 in the supplementary materials: Image by Raimo Suhonen, MD courtesy of DermNetNZ (ExternalRef removed). Image used with permission from Raimo Suhonen, MD and DermNetNZ. For the photo associated with vignette 3 in the supplementary materials: Human hand with dermatitis.jpg by James Heilman, MD courtesy of Wikimedia Commons licensed under CC BY-SA 3.0. Go toExternalRef removedto read the full license text. For the photo associated with vignette 4 in the supplementary materials: Image by BSIP SA courtesy of Alamy Inc. is licensed under the Alamy License Agreement purchased for use in magazines and books in perpetuity worldwide. Go toExternalRef removedto read the full license text.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by MAH. The first draft of the manuscript was written by MAH and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.